How do I administer intralesional lidocaine with triamcinolone for keloid treatment, including dosage and interval?

Intralesional Keloid Treatment with Triamcinolone and Lidocaine

For keloid treatment, inject triamcinolone acetonide 10 mg/mL (0.2-2.0 mL per lesion) intralesionally, with treatment repeated every 4 weeks, using lidocaine mixed 1:1 with triamcinolone or injected separately for pain control. 1

Triamcinolone Dosing

The evidence supports the following approach:

• Concentration: Use triamcinolone acetonide 10 mg/mL 1
• Volume per injection: 0.2-2.0 mL depending on lesion size 1
• Dosing by lesion size: Studies report 1-20 mg/cm² (though this varies widely in practice) 2
• Maximum per session: Do not exceed 40-80 mg total triamcinolone per treatment session 3, 4

The FDA label indicates that for intralesional use, doses of 2.5-15 mg per injection site are typical, with larger areas receiving up to 40 mg 3. A practical approach used successfully involves 40 mg/mL concentration mixed with hyaluronidase and lidocaine 4.

Lidocaine Administration for Pain Control

Lidocaine should be mixed directly with triamcinolone in a 1:1 ratio, as this provides effective anesthesia during the injection itself 5, 6. The evidence shows:

• Mixing approach: Combine 1% lidocaine with triamcinolone acetonide in equal volumes before injection 5
• Dosing limits: For adults, do not exceed 4.5 mg/kg lidocaine without epinephrine or 7.0 mg/kg with epinephrine 7
• Alternative: Some practitioners add 2% lidocaine to the triamcinolone mixture 4

Important caveat: While topical anesthetics reduce needle-stick pain, they do NOT reduce the pain of the actual intralesional injection 5. The lidocaine must be mixed with the triamcinolone to provide benefit during injection.

Injection Technique

The proper technique is critical for both efficacy and safety:

• Injection speed: Inject extremely slowly at 3-6 mL/hour for virtually pain-free administration 6. This is the most important determinant of pain during injection.
• Needle size: Use 26-30 gauge needles 2
• Injection level: Target the keloid center or inject subepidermally/intralesionally 2, 8
• Endpoint: Inject until blanching occurs (whitening of the lesion) 2
• Safety: Always aspirate before injection to avoid intravascular administration 7

Treatment Intervals

Repeat injections every 4 weeks 1, 2. This is the most commonly used interval in randomized controlled trials (50% of studies) and represents standard practice. Some protocols use weekly to monthly intervals, but 4 weeks is the evidence-based standard.

Safety Considerations

Key precautions to prevent complications:

• Avoid subcutaneous fat injection: Inject deeply into the keloid itself, not surrounding tissue, to prevent fat atrophy 3
• Monitor for systemic toxicity: Watch for circumoral numbness, metallic taste, tinnitus, or altered mental status indicating lidocaine toxicity 7
• Use incremental dosing: Inject slowly in small increments rather than rapid bolus 7

Expected Outcomes and Follow-up

• Response assessment: Evaluate reduction in keloid height, volume, and symptoms (pain, itch) at each visit 2
• Recurrence monitoring: Follow patients for at least 6-12 months, as recurrence rates with triamcinolone combinations range from 7.5-23.3% 9
• Combination therapy: Consider adding 5-fluorouracil or other agents if monotherapy fails, though this increases complexity 10, 9

Common Pitfalls to Avoid

1. Injecting too rapidly: This is the primary cause of pain. Slow injection (3-6 mL/hour) dramatically reduces discomfort 6
2. Using topical anesthetics alone: These only help with needle-stick pain, not injection pain 5
3. Inadequate follow-up: Many studies follow patients for only 1-3 months, missing late recurrences 9
4. Subcutaneous injection: This causes fat atrophy rather than treating the keloid 3